| Literature DB >> 31858823 |
Marc Heydenreich1,2, Christian Puta3,4, Holger Hw Gabriel3, Andre Dietze1,2, Peter Wright5, Dirk-Henrik Zermann1,2.
Abstract
OBJECTIVE: To investigate the effect of a new therapeutic approach, using an oscillating rod to strength the pelvic floor and deep abdominal musculature and to speed up recovery of continence after radical prostatectomy.Entities:
Keywords: Oscillating rod; continence exercises; prostate cancer; radical prostatectomy; urinary incontinence
Mesh:
Year: 2019 PMID: 31858823 PMCID: PMC7029439 DOI: 10.1177/0269215519893096
Source DB: PubMed Journal: Clin Rehabil ISSN: 0269-2155 Impact factor: 3.477
Figure 1.Design of the study (CONSORT flow diagram).
Baseline values of demographic and clinical characteristics (mean (SD)).
| Baseline | |||
|---|---|---|---|
| Intervention group | Control group | 95% CI for mean difference | |
| Mean (SD) | Mean (SD) | ||
| ( | ( | ||
| Age (year) | 64.0 (6.5) | 64.3 (7.4) | −2.3 to 1.7 |
| Size (cm) | 1.77 (0.1) | 1.76 (0.1) | −0.01 to 0.02 |
| Weight (kg) | 85.5 (12.0) | 83.9 (11.7) | −1.8 to 5.1 |
| BMI (kg/m²) | 27.4 (3.3) | 27.0 (3.5) | −0.6 to 1.3 |
| Abdominal girth (cm) | 101.2 (9.4) | 100.8 (10.3) | −2.5 to 3.3 |
| Waist/hip (cm) | 0.57 (0.1) | 0.57 (0.1) | −0.02 to 0.02 |
| Catheter days | 11.4 (7.2) | 11.7 (7.5) | −2.5 to 1.8 |
| Frequencies actual number (%) | Frequencies actual number (%) | ||
| Surgical techniques | |||
| Abdominal laparotomy | 53 (57.0) | 54 (59.3) | |
| Perineal | 5 (5.4) | 3 (3.3) | |
| Laparoscopy | 25 (26.9) | 25 (27.5) | |
| Robotic | 10 (10.8) | 9 (9.9) | |
| Tumor classifications | |||
| 2a | 6 (6.5) | 5 (5.5) | |
| 2b | 2 (2.2) | − | |
| 2c | 57 (61.3) | 61 (67.0) | |
| 3a | 16 (17.2) | 15 (16.5) | |
| 3b | 12 (12.9) | 10 (11.0) | |
BMI, body mass index; CI, confidence interval; SD, standard deviation.
Data are presented as mean (SD).
Independent t-test, statistically significant (P < 0.05).
Comparisons of urinary incontinence and health-related quality of life between intervention and control group before and after three weeks of treatment.
| Variables | Intervention group ( | Control group ( | Effect size between groups | |||||
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Effect size within group | Mean (SD) | Mean (SD) | Effect size within group | |||
| Baseline | After three weeks of treatment | Baseline | After three weeks of treatment | |||||
| 1-hour pad test (g) | 22.6 (31.2) | 8.5 (13.2) | 0.67 | 23.0 (28.3) | 18.1 (30.9) | 0.24 | 0.008 | 0.39 |
| 24-hour pad test (g) | 242.9 (269.6) | 126.7 (171.1) | 0.79 | 237.6 (273.0) | 180.9 (258.8) | 0.39 | 0.012 | 0.27 |
| FACT-P questionnaire | 31.1 (6.4) | 34.1 (5.9) | 0.56 | 29.8 (6.5) | 32.1 (5.1) | 0.39 | 0.017 | 0.16 |
FACT-P, Functional Assessment of Cancer Therapy-Prostate (quality of life questionnaire); g, gram; SD, standard deviation.
Data are presented as mean (SD).
Independent t-test, statistically significant (P < 0.05).
Subgroup analysis of the 1-hour pad test between intervention and control group before and after three weeks of treatment.
| Variables |
| Intervention group ( |
| Control group ( | Effect size between groups | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Effect size within group | Mean (SD) | Mean (SD) | Effect size within group | |||||
| Classification 1-hour pad test (g) | Baseline | After three weeks | Baseline | After three weeks | ||||||
| <10 g (mild) | 50 | 3.0 (2.7) | 0.8 (1.9) | 0.93 | 45 | 2.7 (2.7) | 1.6 (3.2) | 0.36 | 0.051 | 0.40 |
| 11–50 g (moderate) | 31 | 28.2 (11.0) | 15.4 (13.3) | 1.18 | 32 | 27.3 (8.6) | 21.8 (20.1) | 0.26 | 0.094 | 0.74 |
| >50 g (high) | 12 | 89.6 (32.5) | 23.0 (17.6) | 1.81 | 14 | 78.1 (24.3) | 62.6 (49.9) | 0.44 | 0.003 | 1.78 |
g, gram; SD, standard deviation.
Data are presented as mean (SD).
Independent t-test, statistically significant (P < 0.05).
Subgroup analysis of 1-hour pad test compared with health-related quality of life for intervention and control group before and after three weeks of treatment.
| Variables |
| Intervention group ( |
| Control group ( | Effect size between groups | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Effect size within group | Mean (SD) | Mean (SD) | Effect size within group | |||||
| Classification 1-hour pad test (g) | FACT-P baseline | FACT-P after three weeks | FACT-P baseline | FACT-P after three weeks | ||||||
| <10 g (mild) | 50 | 32.7 (5.6) | 35.5 (5.3) | 0.63 | 45 | 29.2 (6.2) | 32.2 (5.1) | 0.55 | 0.003 | 0.03 |
| 11–50 g (moderate) | 31 | 28.9 (6.9) | 32.6 (6.8) | 0.60 | 32 | 31.3 (7.2) | 32.6 (5.1) | 0.20 | 0.990 | 0.34 |
| >50 g (high) | 12 | 29.9 (6.2) | 31.8 (3.6) | 0.31 | 14 | 28.4 (5.0) | 30.9 (5.1) | 0.54 | 0.617 | 0.10 |
FACT-P, Functional Assessment of Cancer Therapy-Prostate (quality of life questionnaire); g, gram; SD, standard deviation.
Data are presented as mean (SD).
Independent t-test, statistically significant (P < 0.05).